Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Faculty of Medicine, University of Oslo, Norway.
Age Ageing. 2018 Jan 1;47(1):42-47. doi: 10.1093/ageing/afx121.
in the After Eighty study (ClinicalTrials.gov.number, NCT01255540), patients aged 80 years or more, with non-ST-elevation myocardial infarction (NSTEMI), and unstable angina pectoris (UAP), were randomised to either an invasive or conservative management approach. We sought to compare the effects of these management strategies on health related quality of life (HRQOL) after 1 year.
the After Eighty study was a prospective randomised controlled multicenter trial. In total, 457 patients aged 80 or over, with NSTEMI or UAP, were randomised to either an invasive strategy (n = 229, mean age: 84.7 years), involving early coronary angiography, with immediate evaluation for percutaneous coronary intervention, coronary artery bypass graft, optimal medical therapy, or to a conservative strategy (n = 228, mean age: 84.9 years). The Short Form 36 health survey (SF-36) was used to assess HRQOL at baseline, and at the 1-year follow-up.
baseline SF-36 completion was achieved for 208 and 216 patients in the invasive and conservative groups, respectively. A total of 137 in the invasive group and 136 patients in the conservative group completed the SF-36 form at follow-up. When comparing the changes from follow-up to baseline (delta) no significant changes in quality-of-life scores were observed between the two strategies in any of the domains, expect for a small but statistically significant difference in bodily pain. This difference in only one of the SF-36 subscales may not necessarily be clinically significant.
from baseline to the 1 year follow-up, only minor differences in change of HRQOL as measured by SF-36 were seen by comparing an invasive and conservative strategy.
CLINICALTRIALS.GOV IDENTIFIER: NCT01255540.
在 80 岁以上研究(ClinicalTrials.gov 编号:NCT01255540)中,年龄 80 岁及以上的非 ST 段抬高型心肌梗死(NSTEMI)和不稳定型心绞痛(UAP)患者被随机分为侵入性或保守性管理方法。我们试图比较这两种管理策略对 1 年后健康相关生活质量(HRQOL)的影响。
80 岁以上研究是一项前瞻性随机对照多中心试验。共有 457 名年龄 80 岁及以上的 NSTEMI 或 UAP 患者被随机分为侵入性策略组(n=229,平均年龄:84.7 岁),包括早期冠状动脉造影,立即评估经皮冠状动脉介入治疗、冠状动脉旁路移植术、最佳药物治疗,或保守策略组(n=228,平均年龄:84.9 岁)。使用健康调查简表 36 项(SF-36)在基线和 1 年随访时评估 HRQOL。
在侵入性和保守性组中,基线 SF-36 完成情况分别为 208 例和 216 例。在侵入性组中有 137 例和在保守性组中有 136 例患者完成了 SF-36 表格随访。当比较从随访到基线的变化(Delta)时,在任何一个领域,两种策略之间的生活质量评分都没有显著变化,除了在身体疼痛方面有一个小但统计学上显著的差异。SF-36 子量表之一的这种差异可能并不一定具有临床意义。
从基线到 1 年随访,通过比较侵入性和保守性策略,仅观察到 SF-36 测量的 HRQOL 变化的微小差异。
NCT01255540。